Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-17 Sale(A) |
2020-12-21 3:35 pm |
Surface Oncology Inc. | SURF | Atlas Venture Fund IX L.P. Atlas Venture Associates IX L.P. Atlas Venture Associates IX LLC 10% Owner |
1,700,000 | $8.1 | $13,770,000 | 2,945,453 (Direct) |
View |
| 2020-12-17 Sale |
2020-12-21 1:32 pm |
Surface Oncology Inc. | SURF | GRAYZEL DAVID S. Director |
1,700,000 | $18.1 | $30,770,000 | 2,945,453 (Indirect) |
View |
| 2020-12-17 Sale |
2020-12-21 1:32 pm |
Surface Oncology Inc. | SURF | Atlas Venture Fund IX L.P. Atlas Venture Associates IX L.P. Atlas Venture Associates IX LLC 10% Owner |
1,700,000 | $18.1 | $30,770,000 | 2,945,453 (Direct) |
View |
| 2020-12-15 Sale |
2020-12-17 8:00 pm |
Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer |
1,000 | $10.48 | $10,480 | 98,000 (Direct) |
View |
| 2020-12-11 Sale |
2020-12-15 8:00 pm |
Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer |
1,405 | $10.05 | $14,120 | 99,000 (Direct) |
View |
| 2020-11-11 Sale |
2020-11-13 8:00 pm |
Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer |
595 | $10.05 | $5,980 | 100,405 (Direct) |
View |
| 2020-10-14 Sale |
2020-10-16 8:02 pm |
Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer |
4,000 | $10.05 | $40,200 | 101,000 (Direct) |
View |
| 2020-09-01 Sale |
2020-09-03 4:17 pm |
Surface Oncology Inc. | SURF | EcoR1 Capital LLC 10% Owner |
332,780 | $7.1419 | $2,376,681 | 4,701,081 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-11-25 Exercise |
2020-11-27 8:00 pm |
N/A 2026-12-09 |
Surface Oncology Inc. | SURF | FEES JESSICA See Remarks |
1,383 | $0 | 145,196 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-27 8:00 pm |
N/A N/A |
Surface Oncology Inc. | SURF | FEES JESSICA See Remarks |
174 | $4.27 | 145,196 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-27 8:00 pm |
N/A N/A |
Surface Oncology Inc. | SURF | FEES JESSICA See Remarks |
982 | $5.412 | 145,196 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-27 8:00 pm |
N/A N/A |
Surface Oncology Inc. | SURF | FEES JESSICA See Remarks |
227 | $4.136 | 145,196 (Direct) |
View |
| 2020-10-28 Exercise |
2020-10-30 8:30 pm |
N/A 2026-12-09 |
Surface Oncology Inc. | SURF | FEES JESSICA See Remarks |
4,895 | $0 | 115,560 (Direct) |
View |
| 2020-10-28 Exercise |
2020-10-30 8:30 pm |
N/A N/A |
Surface Oncology Inc. | SURF | FEES JESSICA See Remarks |
122 | $4.27 | 115,560 (Direct) |
View |
| 2020-10-28 Exercise |
2020-10-30 8:30 pm |
N/A N/A |
Surface Oncology Inc. | SURF | FEES JESSICA See Remarks |
4,773 | $4.136 | 115,560 (Direct) |
View |